凯睿思生命科学 CAI
$25.23 −$0.80 (-3.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $25.15 -0.32%
开盘$26.41
昨收$26.03
当日区间$24.09 – $26.57
成交量10.29M
市值$7.24B
市盈率（TTM）75.3
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$263.71M+45.4% YoY
营业利润$26.93M+249.7% YoY
净利润-$637,000.00+99.1% YoY
摊薄每股收益$0.00+100.0% YoY
自由现金流$6.40M+8.5% YoY
经营现金流$28.48M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率69.7%
营业利润率15.5%
净利率10.6%
净资产收益率20.1%
资产收益率9.6%
投入资本回报率12.2%
流动比率5.53
负债/资产比率51.9%
现金及投资$793.12M
总负债$446.04M
净现金（净负债）$347.08M
自由现金流/营收12.5%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $263.71M | $216.17M | $812.03M | $292.89M | $216.83M |
| 营业总收入 | $263.71M | $216.17M | $812.03M | $292.89M | $216.83M |
| 营业成本 | $84.12M | $74.83M | $272.87M | $71.97M | $69.33M |
| 毛利润 | $179.60M | $141.35M | $539.17M | $220.91M | $147.51M |
| 营业费用 | $152.67M | $136.07M | $494.06M | $132.50M | $114.86M |
| 销售及管理费用 | $120.31M | $104.75M | $392.47M | $100.66M | $93.24M |
| -销售及营销费用 | $53.76M | $45.04M | $167.51M | $44.15M | $41.27M |
| -管理费用 | $66.55M | $59.71M | $224.97M | $56.51M | $51.97M |
| 研发费用 | $32.36M | $31.32M | $101.58M | $31.85M | $21.62M |
| 营业利润 | $26.93M | $5.28M | $45.11M | $88.41M | $32.64M |
| 非经营性利息净收入（支出） | -$2.41M | -$5.98M | -$40.36M | -$4.34M | -$6.15M |
| 非经营性利息收入 | $6.82M | $6.83M | $16.50M | $7.02M | $7.36M |
| 非经营性利息支出 | $9.23M | $12.81M | $56.85M | $11.36M | $13.51M |
| 其他收入（支出） | -$25.13M | $49,000.00 | -$72.85M | -$2.11M | -$2.17M |
| 特殊收益（费用） | -$25.23M | – | -$19.90M | -$1.97M | $0.00 |
| -减：其他特殊支出 | $25.23M | – | $19.90M | $1.97M | – |
| 其他非经营性收入（支出） | $101,000.00 | $49,000.00 | -$665,000.00 | -$148,000.00 | -$89,000.00 |
| 税前利润 | -$614,000.00 | -$644,000.00 | -$68.09M | $81.96M | $24.33M |
| 税费 | $23,000.00 | -$134,000.00 | $0.00 | $0.00 | $0.00 |
| 净利润 | -$637,000.00 | -$510,000.00 | -$68.09M | $81.96M | $24.33M |
| 持续经营利润 | -$637,000.00 | -$510,000.00 | -$68.09M | $81.96M | $24.33M |
| 归属母公司净利润 | -$637,000.00 | -$510,000.00 | -$68.09M | $81.96M | $24.33M |
| 其他优先股股息 | $0.00 | $0.00 | $85.43M | $0.00 | $0.00 |
| 归属普通股股东净利润 | -$637,000.00 | -$510,000.00 | -$537.96M | $81.96M | $24.33M |
| 基本每股收益 | $0.00 | $0.00 | -$3.22 | $0.29 | $0.09 |
| 摊薄每股收益 | $0.00 | $0.00 | -$3.22 | $0.28 | $0.08 |
| 证券出售收益 | – | – | -$52.29M | $0.00 | -$2.08M |
| 优先股股息 | – | – | $384.44M | $0.00 | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.23B | $1.16B | $1.13B | $1.13B | $984.57M |
| 流动资产合计 | $1.06B | $1.01B | $997.80M | $997.80M | $854.25M |
| 现金及现金等价物与短期投资 | $793.12M | $823.46M | $798.57M | $798.57M | $755.49M |
| -现金及现金等价物 | $690.92M | $821.15M | $796.27M | $796.27M | $753.22M |
| -短期投资 | $102.20M | $2.32M | $2.30M | $2.30M | $2.27M |
| 应收款 | $116.89M | $90.52M | $112.14M | $112.14M | $26.70M |
| -应收账款 | $116.89M | $90.52M | $112.14M | $112.14M | $26.70M |
| 预付资产 | $18.93M | $19.62M | $19.59M | $19.59M | $18.66M |
| 存货 | $123.79M | $76.29M | $63.63M | $63.63M | $49.30M |
| 其他流动资产 | $5.11M | $4.29M | $2.36M | $2.36M | $2.58M |
| 非流动资产合计 | $171.79M | $148.21M | $127.86M | $127.86M | $130.33M |
| 固定资产净值 | $95.72M | $82.67M | $63.17M | $63.17M | $64.00M |
| -固定资产原值 | $347.13M | $328.41M | $304.15M | $304.15M | $304.45M |
| -累计折旧 | -$251.42M | -$245.74M | -$240.98M | -$240.98M | -$240.45M |
| 商誉及其他无形资产 | $19.34M | $19.34M | $19.34M | $19.34M | $19.34M |
| -商誉 | $19.34M | $19.34M | $19.34M | $19.34M | $19.34M |
| 其他非流动资产 | $56.73M | $46.20M | $45.35M | $45.35M | $46.99M |
| 负债合计 | $637.89M | $568.90M | $548.36M | $548.36M | $506.21M |
| 流动负债合计 | $191.44M | $143.90M | $127.15M | $127.15M | $86.03M |
| 应付款 | $85.99M | $69.80M | $39.21M | $39.21M | $29.00M |
| -应付账款 | $85.99M | $69.80M | $39.21M | $39.21M | $29.00M |
| 一年内应计费用 | $62.60M | $34.23M | $25.11M | $25.11M | $26.39M |
| 短期债务及融资租赁负债 | $6.55M | $6.01M | $6.53M | $6.53M | $6.61M |
| -一年内到期债务 | $178,000.00 | $173,000.00 | – | – | $164,000.00 |
| -一年内到期融资租赁负债 | $6.37M | $5.84M | $6.53M | $6.53M | $6.45M |
| 一年内递延负债 | $20.52M | $24.97M | $24.49M | $24.49M | $2.79M |
| 其他流动负债 | $327,000.00 | $327,000.00 | $327,000.00 | $327,000.00 | $327,000.00 |
| 非流动负债合计 | $446.45M | $425.00M | $421.21M | $421.21M | $420.18M |
| 长期债务及融资租赁负债 | $445.86M | $424.95M | $421.16M | $421.16M | $420.12M |
| -长期债务 | $392.97M | $381.40M | $378.45M | $378.45M | $376.30M |
| -长期融资租赁负债 | $52.88M | $43.55M | $42.71M | $42.71M | $43.83M |
| 衍生产品负债 | $53,000.00 | $53,000.00 | $53,000.00 | $53,000.00 | $53,000.00 |
| 一年以上递延负债 | $539,000.00 | – | – | – | – |
| 可转换优先证券 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 股东权益合计 | $591.73M | $593.49M | $577.31M | $577.31M | $478.36M |
| 股东权益 | $591.73M | $593.49M | $577.31M | $577.31M | $478.36M |
| 股本 | $283,000.00 | $284,000.00 | $283,000.00 | $283,000.00 | $283,000.00 |
| -普通股 | $283,000.00 | $284,000.00 | $283,000.00 | $283,000.00 | $283,000.00 |
| 资本公积 | $3.14B | $3.16B | $3.14B | $3.14B | $3.12B |
| 留存收益 | -$2.55B | -$2.55B | -$2.55B | -$2.55B | -$2.63B |
| 减：库存股 | $0.00 | $16.90M | $16.90M | $16.90M | $16.92M |
| 不影响留存收益的损益 | $529,000.00 | $893,000.00 | $936,000.00 | $936,000.00 | $748,000.00 |
| 受限现金 | – | – | $1.53M | $1.53M | $1.52M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $28.48M | $32.88M | $83.16M | $44.78M | $62.43M |
| 持续经营经营活动现金流净额 | $28.48M | $32.88M | $83.16M | $44.78M | $62.43M |
| 持续经营净利润 | -$637,000.00 | -$510,000.00 | -$68.09M | $81.96M | $24.33M |
| 折旧、折耗与摊销 | $6.54M | $5.07M | $22.62M | $4.29M | $4.87M |
| 其他非现金项目 | $1.50M | $4.16M | $19.57M | $2.30M | $3.41M |
| 营运资金变动 | -$26.37M | $8.29M | -$33.13M | -$59.10M | $14.09M |
| -应收款变动 | -$26.37M | $21.62M | -$29.79M | -$91.02M | $24.19M |
| -存货变动 | -$48.31M | -$13.33M | -$20.75M | -$9.61M | -$8.52M |
| -预付资产变动 | $895,000.00 | -$1.55M | -$5.15M | -$345,000.00 | -$2.54M |
| -应付账款及应计费用变动 | $48.34M | $1.39M | $22.51M | $41.50M | $1.62M |
| -其他流动资产变动 | -$924,000.00 | $153,000.00 | $48,000.00 | $374,000.00 | -$660,000.00 |
| 投资活动现金流净额 | -$122.19M | -$10.34M | -$16.26M | -$5.09M | -$7.10M |
| 持续经营投资活动现金流净额 | -$122.19M | -$10.34M | -$16.26M | -$5.09M | -$7.10M |
| 筹资活动现金流 | -$36.90M | $824,000.00 | $664.99M | $3.40M | -$21.10M |
| 持续经营筹资活动现金流净额 | -$36.90M | $824,000.00 | $664.99M | $3.40M | -$21.10M |
| 债务发行及偿还净额 | -$12.85M | -$40,000.00 | $27.76M | $3.96M | -$4.02M |
| 普通股发行净额 | -$21.36M | $0.00 | $528.35M | -$91,000.00 | $0.00 |
| 股票期权行使所得 | $3.68M | $920,000.00 | $17.91M | $3.86M | $1.15M |
| 其他筹资费用净额 | -$6.37M | -$56,000.00 | -$30.26M | -$4.33M | -$18.23M |
| 期末现金余额 | $692.75M | $823.39M | $800.04M | $800.04M | $756.98M |
| 现金净变动 | -$130.62M | $23.36M | $731.88M | $43.09M | $34.23M |
| 期初现金余额 | $823.39M | $800.04M | $68.03M | $756.98M | $722.69M |
| 汇率变动影响 | -$27,000.00 | -$10,000.00 | $130,000.00 | -$29,000.00 | $62,000.00 |
| 自由现金流 | $6.40M | $22.53M | $66.90M | $39.69M | $55.33M |
| 固定资产购置及出售净额 | – | -$10.34M | -$16.26M | -$5.09M | – |
| 持续经营损益 | – | – | $19.90M | $1.97M | $0.00 |
| 投资购置及出售净额 | – | – | $0.00 | $0.00 | $0.00 |
| 优先股发行净额 | – | – | $121.24M | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 CAI。